1-2 of 2
Alain faivre Chauvet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Dose-Escalation Study of 90 yttrium-Labeled Anti-CD22 Epratuzumab Tetraxetan in Adults with Refractory/Relapsed CD22 + B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Free
Patrice Chevallier, MD PhD, Thomas Eugene, MD, Nelly Robillard, Françoise Isnard, MD, Franck E Nicolini, MD PhD, Martine Escoffre-Barbe, MD, Françoise Huguet, Mathilde Hunault, Antoine Marcais, MD, Thierry Guillaume, Jacques Delaunay, MD, Pierre Peterlin, MD, Xavier Thomas, MD PhD, Norbert Ifrah, Simona Lapusan, Caroline bodet-Milin, MD, Alain faivre Chauvet, Claire Le Houerou, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Françoise Kraeber-Bodere, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3708.
https://doi.org/10.1182/blood.V124.21.3708.3708
Published: 2014
Journal Articles

Consolidation Anti-CD22 Fractionated Radioimmunotherapy with 90Y Epratuzumab Tetraxetan Following R-CHOP In Elderly DLBCL Patients

Free
Françoise kraeber-Bodere, Hervé Maisonneuve, MD, Thierry Lamy, Steven Le Gouill, Eric Deconninck, MD, Amandine Pallardy, Caroline bodet-Milin, Noel Milpied, MD, Nadine Morineau, MD, Charles Foussard, MD, Thomas Gastinne, Remy Gressin, MD, Olivier Tournilhac, MD, PhD, Emmanuel Gyan, MD, PhD, Anne Moreau, Alain Faivre-Chauvet, Anne-Laure Cazeau, Etienne Garin, Jean-Philippe Vuillez, Jean-François Chatal, Jean-Luc Harousseau, Philippe Moreau, William Wegener, MD, PhD, David Goldenberg, Pierre Soubeyran, MD
Journal: Blood
Blood (2010) 116 (21): 2875.
https://doi.org/10.1182/blood.V116.21.2875.2875
Published: 2010